Previous studies have indicated that ZEB2 induces EMT by inhibiting the expression of E-cadherin, promotes cell migration and invasion, and plays a pro-cancer role in many types of cancer, such as breast cancer [57], hepatocellular carcinoma [58] and NSCLC [59, 60]. Here, ZEB2 is linked to hepatocellular carcinoma.